Alteration of microRNAs regulated by c-Myc in Burkitt Lymphoma

PLoS ONE

Volumn 5, Issue 9, 2010, Pages

  Onnis, Anna ^a   de Falco, Giulia ^a   Antonicelli, Giuseppina ^a   Onorati, Monica ^a   Bellan, Cristiana ^a   Sherman, Omar ^b   Sayed, Shaheen ^b   Leoncini, Lorenzo ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b Aga Khan University   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 9; MYC PROTEIN; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BURKITT LYMPHOMA; CHILD; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; NUCLEOTIDE SEQUENCE; ONCOGENE MYC; PROTEIN EXPRESSION; RNA METHYLATION; RNA TRANSPORT; TRANSCRIPTION REGULATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BURKITT LYMPHOMA; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; DNA METHYLATION; E2F1 TRANSCRIPTION FACTOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-MYC; TRANSLOCATION, GENETIC; YOUNG ADULT;

EID: 77958564465     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012960     Document Type: Article

References (35)

1. Pelengaris S, Khan M, Evan G (2002) c-MYC: more than just a matter of life and death. Nat Rev Cancer 2: 764-76.
2. Taub R, Kirsch I, Morton C, Lenoir G, Swan D, et al. (1982) Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc Natl Acad Sci U S A 79: 7837-41.
3. Chung HJ, Levens D (2005) c-myc expression: keep the noise down! Mol Cells 20: 157-66.
4. Gallant P (2005) Myc, cell competition, and compensatory proliferation. Cancer Res 65: 6485-7.
5. Johnston LA, Gallant P (2002) Control of growth and organ size in Drosophila. Bioessays 24: 54-64.
6. De la Cova C, Abril M, Bellosta P, Gallant P, Johnston LA, et al. (2004) Drosophila myc regulates organ size by inducing cell competition. Cell 117: 107-16.
7. Moreno E, Basler K (2004) dMyc transforms cells into super-competitors. Cell 117: 117-29.
8. Hummel M, Bentink S, Berger H, Klapper W, Wessendorf S, et al. (2006) A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med 354: 2419-30.
9. Dave SS, Fu K, Wright GW, Lam LT, Kluin P, et al. (2006) Molecular diagnosis of Burkitt's lymphoma. N Engl J Med 354: 2431-42.
10. Leucci E, Cocco M, Onnis A, De Falco G, van Cleef P, et al. (2008) MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation. J Pathol 216: 440-50.
11. Baudino TA, Maclean KH, Brennan J, Parganas E, Yang C, et al. (2003) Mycmediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss. Mol Cell 11: 905-914.
12. Ambros V (2004) The functions of animal microRNAs Nature 431: 350-355.
13. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism and function. Cell 116: 281-297.
14. Croce CM (2009) Causes and consequences of microRNA dysregulation in cancer. Nature Reviews Genetics 10: 704-714.
15. Mestdagh P, Fredlund E, Pattyn F, Schulte JH, Muth D, et al. (2010) MYCN/c- MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors. Oncogene 29: 1394-404.
16. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT, et al. (2005) c- Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839-843.
17. Sun Y, Wu J, Wu SH, Thakur A, Bollig A, et al. (2009) Expression profile of microRNAs in c-Myc induced mouse mammary tumors. Breast Cancer Res Treat 118: 185-96.
18. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, et al. (2010) miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 12: 247-56.
19. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, et al. (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press.
20. De Falco G, Leucci E, Lenze D, Piccaluga PP, Claudio PP, et al. (2007) Gene expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt's lymphoma cell lines and primary tumors. Blood 110: 1301-7.
21. Sethupathy P, Corda B, Hatzigeorgiou AG (2006) TarBase: A comprehensive database of experimentally supported animal microRNA targets. RNA 12: 192-197.
22. Ambros V, Bartel B, Bartel DP, Burge CB, Carrington JC, et al. (2003) A uniform system for microRNA annotation. RNA 9: 277-279.
23. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods. 25: 402-8.
24. Bellan C, Lazzi S, Hummel M, Palummo N, de Santi M, et al. (2005) Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas Blood. 106: 1031-1036.
25. Lazzi S, Bellan C, Onnis A, De Falco G, Sayed S, et al. (2009) Rare lymphoid neoplasms coexpressing B- and T-cell antigens. The role of PAX-5 gene methylation in their pathogenesis. Hum Pathol 40: 1252-61.
26. Lehmann U, Hasemeier B, Christgen M, Mueller M, Roemermann D, et al. (2008) Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J Pathol 214: 17-24.
27. Leone G, DeGregori J, Sears R, Jakoi L, Nevins JR, et al. (1997) Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature 387: 422-6. Erratum in: Nature 1997;387: 422-6. Erratum in: Nature 1997;387: 932.
28. Coller HA, Forman JJ, Legesse-Miller A (2007) ''Myc'ed messages'': myc induces transcription of E2F1 while inhibiting its translation via a microRNA polycistron. PLoS Genet 3: e146.
29. Scaria V, Hariharan M, Pillai B, Maiti S, Brahmachari SK (2007) Host-virus genome interactions: macro roles for microRNAs Cellular Microbiology 9: 784-2794.
30. Scaria V, Hariharan M, Maiti S, Pillai B, Brahmachari SK (2006) Host-virus interaction: a new role for microRNAs Retrovirology 3: 1-9.
31. Motsch N, Pfuhl T, Mrazek J, Barth S, Grässer FA (2007) Epstein-Barr virusencoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a. RNA Biol 4: 131-7.
32. Leucci E, Onnis A, Cocco M, De Falco G, Imperatore F, et al. (2010) B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression. Int J Cancer 126: 1316-26.
33. Hasenclever D, Diehl V (1998) A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med 339: 1506-1514.
34. Sevilla DW, Gong JZ, Goodman BK, Buckley PJ, Rosoff P, et al. (2007) Clinicopathologic Findings in High-Grade B-Cell Lymphomas With Typical Burkitt Morphologic Features but Lacking the MYC Translocation. Am J Clin Pathol 128: 981-991.
35. Deng S, Calin GA, Croce CM, Coukos G, Zhang L, et al. (2008) Mechanisms of microRNA deregulation in human cancer. Cell Cycle 7: 2643-6.